Back to search

Eradication of minimal residual disease in hairy cell leukemia

Data up to Jan 2025

Published2006
Citations126
References39

Total Citations Per Year

Abstract

References (39)

Alpha Interferon for Induction of Remission in Hairy-Cell Leukemia

1984 • 833 citations

Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712)

2002 • 578 citations

Lasting Remissions in Hairy-Cell Leukemia Induced by a Single Infusion of 2-Chlorodeoxyadenosine

1990 • 521 citations

Long-Term Follow-Up of Patients With Hairy Cell Leukemia After Cladribine Treatment

1998 • 318 citations

Levels of expression of CD19 and CD20 in chronic B cell leukaemias.

1998 • 315 citations

Extended Follow-Up of Patients With Hairy Cell Leukemia After Treatment With Cladribine

2003 • 273 citations

Randomized comparison of pentostatin versus interferon alfa-2a in previously untreated patients with hairy cell leukemia: an intergroup study.

1995 • 268 citations

Lymphoid neoplasms associated with concurrent t(14;18) and 8q24/c-MYC translocation generally have a poor prognosis

2005 • 217 citations

Phase 2 study of a combined immunochemotherapy using rituximab and fludarabine in patients with chronic lymphocytic leukemia

2002 • 209 citations

Gene Expression Profiling of Hairy Cell Leukemia Reveals a Phenotype Related to Memory B Cells with Altered Expression of Chemokine and Adhesion Receptors

2004 • 200 citations

Use of family specific leader region primers for PCR amplification of the human heavy chain variable region gene repertoire

1992 • 190 citations

Splenectomy in hairy cell leukemia: A retrospective multicenter analysis

1981 • 181 citations

Long-term follow-up of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatin.

2000 • 170 citations

Rituximab in relapsed or refractory hairy cell leukemia

2003 • 162 citations

Phase 2 study of rituximab in the treatment of cladribine-failed patients with hairy cell leukemia

2003 • 158 citations

Treatment of hairy cell leukemia with recombinant alpha 2 interferon

1985 • 157 citations

Pentostatin in the treatment of advanced hairy cell leukemia.

1989 • 155 citations

Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA)

1992 • 154 citations

Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA): long-term follow-up of the Northwestern University experience

2005 • 139 citations

Treatment of hairy-cell leukemia with cladribine: response, toxicity, and long-term follow-up.

1997 • 134 citations

Treatment of hairy cell leukemia with recombinant alpha 2 interferon

1985 • 134 citations

Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA)

1992 • 121 citations

PCR Analysis of Immunoglobulin Heavy Chain (IgH) and TcR-γ Chain Gene Rearrangements in the Diagnosis of Lymphoproliferative Disorders: Results of a Study of 525 Cases

2000 • 112 citations

Rituximab, a chimaeric anti‐CD20 monoclonal antibody, in the treatment of hairy cell leukaemia

2001 • 111 citations

Flow cytometry of blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells and lymphocyte subsets after treatment with 2-chlorodeoxyadenosine

1994 • 110 citations

Relapse of hairy cell leukemia after 2-chlorodeoxyadenosine: long-term follow-up of the Northwestern University experience

1996 • 103 citations

Hairy cell leukemia: at the crossroad of somatic mutation and isotype switch

2004 • 95 citations

Long‐term follow‐up of patients with hairy cell leukaemia after treatment with pentostatin or cladribine

1999 • 92 citations

Minimal residual disease may predict bone marrow relapse in patients with hairy cell leukemia treated with 2-chlorodeoxyadenosine

1996 • 91 citations

Efficacy of anti-CD20 monoclonal antibodies (Mabthera) in patients with progressed hairy cell leukemia.

2001 • 91 citations

Flow cytometry of blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells and lymphocyte subsets after treatment with 2-chlorodeoxyadenosine

1994 • 91 citations

Minimal Residual Disease Detection in Hairy Cell Leukemia

2003 • 60 citations

Minimal Residual Disease Detection in Hairy Cell Leukemia Comparison of Flow Cytometric Immunophenotyping With Clonal Analysis Using Consensus Primer Polymerase Chain Reaction for the Heavy Chain Gene

2003 • 55 citations

Clinical manifestations and infectious complications of hairy-cell leukaemia

2003 • 55 citations

Rituximab as treatment for minimal residual disease in hairy cell leukaemia

2004 • 54 citations

Heterogeneous somatic hypermutation status confounds the cell of origin in hairy cell leukemia

2004 • 48 citations

VH gene analysis of hairy cell leukemia reveals a homogeneous mutation status and suggests its marginal zone B-cell origin

2004 • 40 citations

Cladribine in the treatment of hairy-cell leukaemia

2003 • 38 citations

Pentostatin in the treatment of hairy-cell leukemia

2003 • 21 citations

Cited By (0)

No citing papers found in database

Eradication of minimal residual disease in hairy cell leukemia (2006) – Blood | Metascience Observatory Explorer